1. Report Introduction
2. Nonalcoholic Steatohepatitis (NASH) Epidemiology Overview at a Glance
3. Market Share Distribution of Nonalcoholic Steatohepatitis (NASH)
4. Disease Background and Overview: Nonalcoholic Steatohepatitis (NASH)
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. Nonalcoholic Steatohepatitis (NASH) Epidemiology
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. Epidemiology of Nonalcoholic Steatohepatitis (NASH) by Countries
7. United States
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
7.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
7.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
7.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
7.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
8.1.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
8.1.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
8.1.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
8.1.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
8.2.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
8.2.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
8.2.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
8.2.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
8.3.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
8.3.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
8.3.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
8.3.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
8.4.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
8.4.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
8.4.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
8.4.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
8.5.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
8.5.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
8.5.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
8.5.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
9. Japan
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
9.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
9.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
9.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
9.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
10. Unmet Needs
Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific

Note: Certain sections of the table of contents would vary according to the availability of information.